BefejeződöttFázis nélkül
Non-invasive Vagal Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients With Gastroparesis and Related Disorders
A legfontosabb adatok
- Ki végzi
- Johns Hopkins University
- Hol
- Baltimore (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 49 fő vett részt
- Kezdés
- 2021. ápr. 19.
- Befejezés
- 2024. jan. 23.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- nVNS (gammaCore)
- A regiszteradat frissítve
- 2024. október 15.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 19 feltétel megnézéseKevesebb
Ki vehet részt
- Age 18 years or older at registration
- Diagnosis of gastroparesis as documented by gastric emptying scintigraphy (4-hour emptying after a low-fat meal with any combination of 2- and 4-hour retention of >60% and 10%, respectively), or Chronic Unexplained Nausea and Vomiting (CUNV)
- Ongoing symptoms (i.e. Nausea and vomiting, bloating, and abdominal pain) with a nausea score of 3 or more on the patient assessment of upper gastrointestinal disorders-symptom severity index (PAGI-SYM) scale at baseline (moderate to severe nausea)
- Exclusion of other causes of symptoms such as mechanical gastrointestinal obstruction, uncontrolled esophagitis, peptic ulcer disease, etc. By standard radiographic or endoscopic tests
- Use of the following medications on an as-needed basis: ondansetron, promethazine or prochlorperazine but no more than four times a day
Ki nem vehet részt
- A previous surgery of the upper gastrointestinal tract, including vagotomy
- Previous bilateral or right cervical vagotomy
- Implanted with metal cervical spine hardware or has a metallic implant near the gammaCore stimulation site
- Another active disorder, which could explain symptoms in the opinion of the investigator
- Abnormal baseline ECG (e.g. Second- and third-degree heart block, atrial fibrillation, atrial flutter, recent history of ventricular tachycardia or ventricular fibrillation, or clinically significant premature ventricular contraction)
- Currently implanted with an electrical and/or neurostimulator device, including but not limited to cardiac pacemaker or defibrillator, vagal neurostimulator, deep brain stimulator, spinal stimulator, bone growth stimulator, or cochlear implant
- History of carotid endarterectomy or vascular neck surgery on the right side
- Any other condition, which in the opinion of the investigator would impede compliance or hinder the completion of the study
- Failure to give informed consent
- History of prolonged QT interval or a history of clinically significant arrhythmia
- Age < than 18 years
- Pregnancy or nursing
- Use of narcotics more than 3 days per week
- Uncontrolled high blood pressure
Helyszínek itt: Egyesült Államok
- Johns Hopkins Bayview Medical CenterBaltimore, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
The hypothesis of this pilot study is that nVNS will result in relief of nausea by modulation of vagal nerve activity. nVNS is the first non-invasive, handheld medical device applied on the side of the neck and sends gentle, patented mild electrical stimulation through the skin to activate the vagus nerve. nVNS offers a potential alternative to Gastric electrical stimulation (GES) that could eliminate significant risks of injury or illness or identify likely responders to implantable neurostimulator including implanted VNS (iVNS). nVNS could provide a more effective and safer alternative to the use of traditional rescue medications.
A vizsgálat csoportja
- nVNS deviceA vizsgált kezelés
Candidates who, after the screening period are eligible to receive the nVNS device.
Kezelés: nVNS (gammaCore)
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Publikációk
- Non-invasive Vagal Nerve Stimulation Decreases the Need for Rescue Medication for Nausea Exacerbation in Patients with Chronic Nausea and Vomiting.Digestive diseases and sciences, 2026
- A regiszteradat frissítve
- 2024. október 15.